Download View Dr Sameer Rastogi`s Resume / CV

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Rastogi, Sameer
Permanent Mailing Address - BD 256, Avantika, Ghaziabad, UP, India
Preferred Phone: 090132321857
Alternate Phone: +91-9873744260
Email: [email protected]
Current Position:
Starting from 29/06/2015
Assistant Professor, Medical Oncology
Sarcoma Clinic
Dr. B.R.A. IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi
Medical Education:
Maulana Azad Medical College, New Delhi
University of Delhi, India
1/08/2000- 31/12/2005
Degree Awarded: Bachelor of Medicine and Bachelor of Surgery, M.B.B.S
Post Graduate Medical Education:
Residency in Pediatrics
Maulana Azad Medical College, New Delhi
University of Delhi, India
01/05/2006- 06/05/ 2009
Degree awarded: MD, Doctor of Medicine
Fellowship (called DM) in Medical Oncology (Adult and Pediatric combined Medical Oncology
program)
Tata Memorial Cancer Institute, Mumbai
University of Mumbai, India
1/08/ 2010- 31/12/ 2013
Clinical Experience:
01/08/2009-03/07/2010
Senior Resident, Department of Medical Oncology
All India Institute of Medical Sciences, New Delhi, India
01/02/2013- 30/11/2014
Special Registrar, Department of Medical Oncology (Equivalent to clinical instructor)
Breast Cancer Unit
Tata Memorial Cancer Institute, Mumbai, India
University of Maharashtra, India
30/03/2015-26/06/2015
Assistant Professor, Department of Medical Oncology
Gastrointestinal Cancer unit
Tata Memorial Hospital, Mumbai
Research Experience:
01/05/2006- 06/05/ 2009
Supervisor name- Dr B. Talukdar (Pediatric Neurology)
Maulana Azad Medical College, New Delhi, India
Randomized placebo controlled trial for effect of Anti-edema Therapy in Seizure
Recurrence in Neuro - Cysticercosis
01/08/2010- 31/12/ 2013
Supervisor: Dr. Purna Kurkure, Professor (Pediatric Oncology)
Tata Memorial Cancer Institute, India
Systematic Evaluation of patients of all stages of Wilms Tumor treated on WT 10/90
Chemotherapy protocol from Oct 1990-Dec 2006 at Tata Memorial Hospital.
ACORD Fellowship (Australia and Asia Pacific Clinical Oncology Research
Development), 14- 20 September 2014, Australia
Team with Dr Chris Karapentis, Dr Chee Lee and Dr Linda Mileshkin
A protocol for phase I/II study of use of oral methotrexate with etoposide in platinum
resistant ovarian cancer has been developed in 2014, held in Australia in September
2014. Due for IRB submission
1/12/2014-14/02/2015
Clinical Oncology Society of Australia (COSA) Asia Pacific Mentoring Fellowship
Research project on Tele oncology in aboriginal population in Australia and further replicating
tele oncology model in India.
Mentor- Dr Abhishek Joshi
Townsville Hospital, Australia
PEER REVIEWED JOURNAL PUBLICATIONS
 Rastogi S, Bakhshi S. Trabectedin in Soft Tissue Sarcoma: Have We Hit the Bull’s-eye? Journal of
Clinical Oncology. Published online before print on 25th July 2016.
 Kaur, S., Sharma, R., Rastogi, S. Demystifying the Association of Chemotherapy and Cognition: How
Close Are We?” Journal of Clinical Oncology. published online before print on 22nd August 2016.
 Rastogi, S., Aggarwal, A., Organization of Chemotherapy and Systemic Therapy Services in
India: Devil lies in details. DOI: 10.1200/JGO.2016.006742 Journal of Global Oncology -
published online before print October 28, 2016.
 Rastogi S et al. Chemotherapy in non metastatic osteosarcoma: Recent advances and implication for
developing countries, Provisional acceptance, Journal of Global Oncology. Manuscript id
JGO/2016/007336
 Rastogi S, Mishra SV and Aggarwal A. Overall Survival as Primary End Point in Advanced Soft
Tissue Sarcoma and its Surrogates: A Bemusing Mirage. Sarcoma Res Int. 2016; 3(2): 1031.
 Rastogi S, Sankhala KK and Chawla SP. Recent Advances in Advanced Sarcoma Therapy:
Medical Oncologist’s Perspective. SM J Orthop. 2016; 2(3): 1040.
 Sankhala, K., Rastogi, S., Chawla S, Chawla, S.P. A safety evaluation of pazopanib for the
treatment of soft tissue sarcoma. Submitted in Expert evaluation of drug safety.
 Sirohi, B., Rastogi, S., Singh, A., Sheth, V., Dawood S., Ramadwar, M.,Kulkarni, S.,
Shrikhande,S.V.. Use of gemcitabine-platinum in patients with advanced gall bladder cancer: A
more aggressive disease compared to the west, Indian experience. Future Oncol. 2015;
11(8):1191-200
 Sirohi, B., Rastogi S, Dawood, S. Buparlisib in Breast Cancer. Future Oncol. 2015; 11 (10): 14631470.
• Rastogi, S., Sirohi, B., Deodhar, K., Shrikhande, S.V., 2014. Dilemma of DPD deficiency in
colorectal cancer patients -- Is Tegafur the right answer? Colorectal Cancer Vol. 3, No. 4, 315319
• Sirohi, B., Rastogi, S., Dawood, S., Talole, S., Ramadwar, M., Shetty, N, Shrikhande, S.V.
Treatment of patients with advanced gastric cancer – experience from an Indian tertiary cancer
center. Med Oncol. 2014; 31 (10):138.
• Rastogi, S., Gulia, S. Bajpai, J., Ghosh, J., Gupta,S. Oligometastasis in breast cancer: A mini
review. Indian Journal of Medical and Pediatric Oncology (IJMPO). 2014; 35 (3): 203-206
• Sirohi,B., Barreto,S.G., Singh, A., Batra,s., Mittra, A., Rastogi, S., Ramadvar,
M., Shetty, N., Goel, M., Shrikhande, S.V. EOX is just as ‘MAGICal’ as ECF as Perioperative
Chemotherapy for resectable but Locally Advanced Esophago-Gastric Cancer. J Cancer Res
Ther.2014 Oct-Dec; 10(4):866-70
INVITED SUBMISSIONS AND PEER REVIEWED BOOK CHAPTERS
• Rastogi,S., Gupta,S. (2014). Chemotherapy in non-metastatic breast cancer. In
S. Radhakrishna (Ed). Breast diseases: Imaging and clinical management.
Chennai, India: Spingerlink.
• Rastogi,S., Gupta,S. (2014).Targeted therapy in non-metastatic breast cancer.
In S. Radhakrishna (Ed). Breast diseases: Imaging and clinical management.
Chennai, India: Spingerlink.
• Rastogi,S., Goyal,G., Gupta, S. (2014). Endocrine therapy in non-metastatic breast cancer. In S.
Radhakrishna (Ed). Breast diseases: Imaging and clinical management. Chennai, India:
Spingerlink
• Rastogi,S., Gupta,S. (2014). Targeted therapy in non-metastatic breast cancer. In N. Nair (Ed)
Evidence based management guidelines 2014. Mumbai, India: Tata Memorial Hospital.
• Rastogi,S., Gupta, S. Gulia, S. Ghosh J. (2014). Landmark papers in last 3 years. In P. Parikh
(Ed). Converge-breast cancer update 2014. Mumbai, India: Oncology gold standard book series.
• Rastogi,S., Gupta,S. (2014). Clinical trials with Biologicals: Current status and what can be
done.” In L Kumar (Ed). Proceedings of 30th Ranbaxy Science Foundation’s Round Table
Conference on Lifestyle and Cancer with Focus on Cancer Prevention. Delhi, India: Ranbaxy
science foundation
• Rastogi, S., Sirohi, B. (2014). Chemotherapy in gastric cancer. S.V. Shrikhande(Ed). Modern GI
oncology book. Mumbai, India.
• Rastogi, S., Nag, S. (2014). Targeted therapy in uterine cancer: Current status and future. In A
Maheshwari (Ed). Uterine cancer diagnosis and management. Mumbai, India, PublisherSpingerlink.
PRESENTATIONS WITH PUBLISHED ABSTRACTS
• Vora, T., Rastogi, S., Chinnaswamy, G., Arora, B. et al. (2012), Ewing sarcoma family of tumors
(ESFT): Does modality of local therapy impact outcome? Surgery versus radiotherapy versus
combined multimodal approach. Pediatric blood and cancer, 59:991.
• Rastogi, S., Vora, T., Gulia, A., Puri, A., Qureshi, S., Laskar, S. et al. (2012), Extraskeletal Ewings
sarcoma and skeletal Ewing’s sarcoma- Are they different entities? Pediatric blood and cancer,
59:1066-1067.
• Rastogi, S., Kurkure P et al. Is three drug chemotherapy protocol for all stages of wilms tumor
a practical compromise for suboptimal staging in developing country? Is it worth & safe?
Pediatric Blood and Cancer.2014
OTHER ORAL AND POSTER PRESENTATIONS:
• Ewings sarcoma clinicopathologic profile of Indian patients (oral), Pediatric
Hemato-oncology chapter (PHOCON). Mumbai, 25th November 2011.
• TMH experience with Everolimus in mRCC, World Kidney Day-International
Symposium on RCC 2012, Goa.
• Extra skeletal Ewings Sarcoma- Is It Different from Skeletal Ewings Sarcoma,
SIOP (International Society of Pediatric Oncology) 7th October 2012, London,
• Geriatric case poster presentation- Lung cancer- Let’s think beyond palliation,
Indian Cooperative Oncology Network (ICON-30) 2014, Ahmedabad, India,
5th April 2014
• Best thesis presentation, Systematic Evaluation of patients of all stages of
Wilms Tumor treated on WT 10/90 chemotherapy protocol from Oct 1990-Dec
2006 at Tata Memorial Hospital. Indian Cooperative Oncology Network
(ICON-30) 2014, Ahmedabad, India, 4th April 2014
• Princess Margaret Cancer Centre experience with molecular profiling of
metastatic breast cancer to screen for genotype-matched clinical trials, Post
European Breast Cancer Congress, Mumbai, India. May 2014, 10th May 2014
• Is three drug chemotherapy protocols for all stages of Wilms tumor a practical
compromise for suboptimal staging in developing country? Is it worth & safe?
Poster presentation in SIOP 2014, Toronto, Canada.
 Case presentation and panelist in ISMPOCON 2016, Sarcoma workshop. Presented case of
Retroperitoneal sarcoma (Liposarcoma) post surgery and radiotherapy. ISMPOCON 2016, New
Delhi. November 2016
 Debate against the use of high dose methotrexate in non metastatic osteosarcomaOsteosarcoma Update, 2016, New Delhi. November 2016
Talk on “Establishing cancer genetics clinic- From the perspective of Sarcoma physicians.”
3rd Indian Cancer Genetics Conference. Tata Memorial Centre. ICGCW 2016. Organized by
Dr Rajiv Sarin. December 2016
Honorary Memberships

• Editorial member, Lung Cancer Consortium Asia.
• Editorial member, Indian Journal of Medical and Pediatric Oncology
(IJMPO).
• Member, European Society of Medical Oncology (ESMO).
• ASCO member.
• SIOP member (International Society of Pediatric Oncology)
• Young investigator group member SIOP.
• Commentaries on pancreatic cancer India website.
Workshops
• ICON/ ASCO/ NIH (Indian Cooperative Oncology Network/ American
Society of Clinical Oncology/ National Institute of Health Cancer Research
Workshop on clinical trials: September 2012, Nashik, India
• Clinical research methodology workshop 2013, Tata Memorial Hospital
• ICH-GCP (Good Clinical Practice) training, 2014 Tata Memorial Hospital,
India.
Awards and Honors
• Winner of Indian Academy of Pediatrics 2nd IAP (Indian Academy of
Pediatrics quiz) in August 2008
• Manoj Kapoor Memorial gold Medal for best resident, 2009.
• Selected for Essay writing competition for ‘Role of youth against cancer’ (in
first 25 participants) Carcinogenesis foundation USA (held in India, August
2014).
• COSA (Clinical oncology society of Australia) fellowship award for project in
Tele Oncology: December 2014
• SIOP (International society of Pediatric Oncology) 2014, Best Poster Award,
for ‘Is three drug chemotherapy protocol for all stages of Wilms tumor a
practical compromise for suboptimal staging in developing country? Is it
worth & safe?’
• International Society of Pediatric Oncology (SIOP) 2014, Young Investigator
Award. For ‘Is three drug chemotherapy protocols for all stages of Wilms
tumor a practical compromise for suboptimal staging in developing country?
Is it worth & safe?’
Grant Writing Application
Written grant writing application for American Society of Clinical Oncology (ASCO)
conquer cancer foundation. Selected in first 23 out of a total of 75 candidates. It was
written for project named ‘Prospective study of tele oncology in metastatic breast and
ovarian cancer’
Extracurricular activities
– My favourites almost all Dan Brown Series and Alchemist
Socializing with people and travelling to different places. I have been to various countries and
soon will cover the entire world!
- I am fitness freak and whenever possible I hit the gym, run, jog etc.
Convener of Sarcoma work group in AIIMS, First meeting held on 13 th November 2016 in
AIIMS. Chaired by Dr Rath, Dr SVS Deo and Dr D N Sharma